glp 1 migraines Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review | The Journal of Headache and Pain Early Research Shows GLP-1 Drugs

Targeting both simultaneously has the potential to produce weight loss outcomes that neither drug could achieve alone without simply doubling the side effects

Hamrang-Yousefi S, Ng J, Andaloro C

For researchers interested in the broader landscape of growth hormone-adjacent anti-aging peptides, our Tesamorelin vs Sermorelin comparison provides a useful reference point for GH-axis interventions that complement GHK-Cus collagen- and tissue-repair activity

Xue XC et al

Yong JN, Ng CH, Lee CW-M, Chan YY, Tang ASP, Teng M, et al

The Wegovy pill showed roughly similar weight loss and side effects in clinical trials as the Wegovy shot, and will be available by prescription in the US in January, according to Novo Nordisk